Nathan C Coleman1, Majid Ezzati2, Julian D Marshall3, Allen L Robinson4, Richard T Burnett5, C Arden Pope1. 1. Department of Economics, Brigham Young University, Provo, UT, USA. 2. MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK. 3. Department of Civil and Environmental Engineering, University of Washington, Seattle, WA, USA. 4. Engineering and Public Policy, Carnegie Mellon University, Pittsburgh, PA, USA. 5. Health Canada, Ottawa, Ontario, Canada.
Abstract
Background: Exposure to fine particulate matter (PM2.5) air pollution has been linked to increased risk of mortality, especially cardiopulmonary and lung cancer mortality. It is unknown if cancer patients and survivors are especially vulnerable to PM2.5 air pollution exposure. This study evaluates PM2.5 exposure and risk for cancer and cardiopulmonary mortality in cohorts of US cancer patients and survivors. Methods: A primary cohort of 5 591 168 of cancer patients and a 5-year survivor cohort of 2 318 068 was constructed using Surveillance, Epidemiology, and End Results Program data from 2000 to 2016, linked with county-level estimates of long-term average concentrations of PM2.5. Cox proportional hazards models were used to estimate PM2.5-mortality hazard ratios controlling for age-sex-race combinations and individual and county-level covariables. Results: Of those who died, 26% died of noncancer causes, mostly from cardiopulmonary disease. Minimal PM2.5-mortality associations were observed for all-cause mortality (hazard ratio [HR] = 1.01, 95% confidence interval [CI] = 1.00 to 1.03) per 10 µg/m3 increase in PM2.5. Substantial adverse PM2.5-mortality associations were observed for cardiovascular (HR = 1.32, 95% CI = 1.26 to 1.39), chronic obstructive pulmonary disease (HR = 1.10, 95% CI = 1.01 to 1.20), influenza and pneumonia (HR = 1.55, 95% CI = 1.33 to 1.80), and cardiopulmonary mortality combined (HR = 1.25, 95% CI = 1.21 to 1.30). PM2.5-cardiopulmonary mortality hazard ratio was higher for cancer patients who received chemotherapy or radiation treatments. Conclusions: Air pollution is adversely associated with cardiopulmonary mortality for cancer patients and survivors, especially those who received chemotherapy or radiation treatment. Given ubiquitous and involuntary air pollution exposures and large numbers of cancer patients and survivors, these results are of substantial clinical and public health importance.
Background: Exposure to fine particulate matter (PM2.5) air pollution has been linked to increased risk of mortality, especially cardiopulmonary and lung cancer mortality. It is unknown if cancer patients and survivors are especially vulnerable to PM2.5 air pollution exposure. This study evaluates PM2.5 exposure and risk for cancer and cardiopulmonary mortality in cohorts of US cancer patients and survivors. Methods: A primary cohort of 5 591 168 of cancer patients and a 5-year survivor cohort of 2 318 068 was constructed using Surveillance, Epidemiology, and End Results Program data from 2000 to 2016, linked with county-level estimates of long-term average concentrations of PM2.5. Cox proportional hazards models were used to estimate PM2.5-mortality hazard ratios controlling for age-sex-race combinations and individual and county-level covariables. Results: Of those who died, 26% died of noncancer causes, mostly from cardiopulmonary disease. Minimal PM2.5-mortality associations were observed for all-cause mortality (hazard ratio [HR] = 1.01, 95% confidence interval [CI] = 1.00 to 1.03) per 10 µg/m3 increase in PM2.5. Substantial adverse PM2.5-mortality associations were observed for cardiovascular (HR = 1.32, 95% CI = 1.26 to 1.39), chronic obstructive pulmonary disease (HR = 1.10, 95% CI = 1.01 to 1.20), influenza and pneumonia (HR = 1.55, 95% CI = 1.33 to 1.80), and cardiopulmonary mortality combined (HR = 1.25, 95% CI = 1.21 to 1.30). PM2.5-cardiopulmonary mortality hazard ratio was higher for cancer patients who received chemotherapy or radiation treatments. Conclusions: Air pollution is adversely associated with cardiopulmonary mortality for cancer patients and survivors, especially those who received chemotherapy or radiation treatment. Given ubiquitous and involuntary air pollution exposures and large numbers of cancer patients and survivors, these results are of substantial clinical and public health importance.
Authors: Lianne Sheppard; Richard T Burnett; Adam A Szpiro; Sun-Young Kim; Michael Jerrett; C Arden Pope; Bert Brunekreef Journal: Air Qual Atmos Health Date: 2011-03-23 Impact factor: 3.763
Authors: Laura Dwyer-Lindgren; Abraham D Flaxman; Marie Ng; Gillian M Hansen; Christopher J L Murray; Ali H Mokdad Journal: Am J Public Health Date: 2015-04-23 Impact factor: 9.308
Authors: D W Dockery; C A Pope; X Xu; J D Spengler; J H Ware; M E Fay; B G Ferris; F E Speizer Journal: N Engl J Med Date: 1993-12-09 Impact factor: 91.245
Authors: C Arden Pope; Richard T Burnett; George D Thurston; Michael J Thun; Eugenia E Calle; Daniel Krewski; John J Godleski Journal: Circulation Date: 2003-12-15 Impact factor: 29.690
Authors: Aaron J Cohen; Michael Brauer; Richard Burnett; H Ross Anderson; Joseph Frostad; Kara Estep; Kalpana Balakrishnan; Bert Brunekreef; Lalit Dandona; Rakhi Dandona; Valery Feigin; Greg Freedman; Bryan Hubbell; Amelia Jobling; Haidong Kan; Luke Knibbs; Yang Liu; Randall Martin; Lidia Morawska; C Arden Pope; Hwashin Shin; Kurt Straif; Gavin Shaddick; Matthew Thomas; Rita van Dingenen; Aaron van Donkelaar; Theo Vos; Christopher J L Murray; Mohammad H Forouzanfar Journal: Lancet Date: 2017-04-10 Impact factor: 79.321
Authors: C Arden Pope; Jacob S Lefler; Majid Ezzati; Joshua D Higbee; Julian D Marshall; Sun-Young Kim; Matthew Bechle; Kurtis S Gilliat; Spencer E Vernon; Allen L Robinson; Richard T Burnett Journal: Environ Health Perspect Date: 2019-07-24 Impact factor: 9.031
Authors: Helen Strongman; Sarah Gadd; Anthony Matthews; Kathryn E Mansfield; Susannah Stanway; Alexander R Lyon; Isabel Dos-Santos-Silva; Liam Smeeth; Krishnan Bhaskaran Journal: Lancet Date: 2019-08-20 Impact factor: 202.731
Authors: Adriana Albini; Giuseppina Pennesi; Francesco Donatelli; Rosaria Cammarota; Silvio De Flora; Douglas M Noonan Journal: J Natl Cancer Inst Date: 2009-12-10 Impact factor: 13.506
Authors: Sun-Young Kim; Matthew Bechle; Steve Hankey; Lianne Sheppard; Adam A Szpiro; Julian D Marshall Journal: PLoS One Date: 2020-02-18 Impact factor: 3.240
Authors: Eduardo Antuña; Juan Carlos Bermejo-Millo; Enrique Caso-Onzain; Enrique Caso-Peláez; Yaiza Potes; Ana Coto-Montes Journal: Front Bioeng Biotechnol Date: 2022-02-14
Authors: Miyoun Shin; Ok-Jin Kim; Seongwoo Yang; Seung-Ah Choe; Sun-Young Kim Journal: Int J Environ Res Public Health Date: 2022-03-08 Impact factor: 3.390